Ultimately, at the end of the follow-up period, none of the patients with HT showed a biochemically incomplete response, and only one patient had a persistent indeterminate response, due to a slight elevation in basal serum Tg and detectable AbTg antibodies. The gene discussed is TG; the disease is hematocrit.